TradeYourMark® is active in the healthcare sector
The healthcare industry is expanded strongly throughout the World. According to the FTSE-Russell’s Industry Classification Benchmark, it can be divided into 3 macro-sectors: health care provision, medical equipment and services and pharmaceuticals and biotechnology. This growth is driven by the market for medicines, but other sectors like homeopathic products and dietary supplements. TradeYourMark® TradeYourMark® is supporting clients in the purchase and sale of trademarks in Class 5.
Current projects
The healthcare industry is characterized by a wide diversity of activities and professions.
The World Health Organisation (WHO) defines health to be “a state of complete physical, mental and social well-being and [qui]not merely the absence of disease or infirmity”. Therefore, taken in its global sense, healthcare also includes the concept of wellness.
The health sector is not just limits to the market for medicines. It also includes homeopathic products and the manufacture of medical, dental and orthopedic equipment. The sector also includes the manufacture of dietary products and supplements.
The sector covers various different activities. First of all, there are the professions linked to diagnosis and treatment: doctors, nurses, dentists, midwives and pharmacists. It also covers associated professions like paramedics, carers, physiotherapists and pedicurists and those linked to medical devices like opticians and hearing aid manufacturers.
Medicines take centre stage
The leading players in the health sector are pharmaceutical companies. In 2021 the global pharmaceutical market saw a strong growth. The USA is the largest market, far ahead of Europe and China.
Pfizer, Johnson&Johnson, Sanofi and Novartis are amongst the largest global pharmaceutical groups.
New medicines allow progress in treatment. There is a continuous development of new pharmaceutical drugs and patents are granted to new medicines to encourage innovation and research. Once no longer protected by patent, generic manufacturers like Teva or Biogaran produce generic medicines which contain the same active ingredient and dosage as the original product, but at a lower cost.
The market for dietary supplements is growing strongly
Dietary supplements cover generally the classic vitamins and minerals as well as products based on plant extracts.
The market for dietary supplements is seeing significant growth as a result of the public increase in having a healthy lifestyle and diet. This concern has grown during recent years because of the crisis of the healthcare systems.
Italy is the largest European market for dietary supplements followed by Germany and the UK. The biggest players are pharmaceutical giants like GSK and Bayer, but there are also specialist players like French market leader Arkopharma, whose products aim to strengthen immunity against illnesses, combat stress or problems sleeping. Other players, like Oenobiol, are specialized in dietary supplements as beauty products: for example for skincare, haircare and tanning.
The wellness market is a good response to today’s problems
In an anxiety provoking environment, the wellness marketing is developing through the growth of various activities such as yoga, meditation, aqua-gym, Zumba and Nordic walking.
Wellness tourism economy is also booming. Wellness tourism is also a growing sector with spas offering not only massages, but also other services such as facial treatments, body wraps and cryotherapy to provide a global experience for their clients.
Healthcare trademarks
Class 5 is used for various products including pharmaceutical and veterinary products, dietary products with medical uses and dietary supplements.
The health sector is creative and dynamic. . According to European Union Intellectual Property Office statistics, 10,000 trademarks were registered in Class 5 in the EU in 2023.
Special features of trademarks of medicines
Trademarks for medicines are subject to complex regulation, which goes beyond Intellectual Property since it also has implications for public health. It is not possible to register as trademarks “international nonproprietary names” (INNs).
INNs designate the principle active ingredient of a pharmaceutical drug and are hence in the public domain. When marketing names are used for a medical product, it must not create potential confusion with an NNI or with other pharmaceutical products. This is to avoid any risk of creating misunderstandings for consumers about the properties of the product.
TradeYourMark®’s proposition
Many trademarks in the health sector are currently dormant. The pharmaceutical group may have changed their strategy and decided not to use the name or failed to receive the required authorization to it. This stock of trademarks is therefore available for acquirers who would like to launch them. Many companies internationally are looking for European dormant trademarks in the healthcare sector.
TradeYourMark® is well positioned to help give a second life to dormant health and well-being brands. We have a large base of brands which we can propose to our clients.
Some of these brands have been mandated to us by clients who wanted to monetise their portfolio of brands or by our partners such as intellectual property advisors and naming agencies. Others have been identified using an algorithm developed by TradeYourMark®.
Some trademarks are available immediately for prices sometimes for prices as low as 6,000 euros. They meet the needs of clients who wish to have a brand which they can launch quickly, with controlled costs and the security of an already registered trademark.
When clients have specific requirements, we make tailored searches based on a detailed brief provided by the client.
TradeYourMark® client case studies
In 2022, Sanofi decided to adopt a pro-active approach to manage its portfolio of trademarks.
After carrying out a review of their portfolio of trademarks, Sanofi selected a group of around 300 trademarks registered mainly in Europe, Turkey and Brazil.
-
We analysed this portfolio and proposed to group some of the brands into lots.
-
We discussed a valuation methodology with Sanofi, which will form the basis for future discussions with potential acquirers.